Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
McKesson
QuintilesIMS
Baxter
Federal Trade Commission
Teva
Cerilliant
Johnson and Johnson
Dow
Express Scripts

Generated: October 24, 2017

DrugPatentWatch Database Preview

Chlorothiazide; reserpine - Generic Drug Details

« Back to Dashboard

What are the generic sources for chlorothiazide; reserpine and what is the scope of chlorothiazide; reserpine patent protection?

Chlorothiazide; reserpine
is the generic ingredient in five branded drugs marketed by Merck, Mylan, Watson Labs, and Hikma Pharms, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are forty-one drug master file entries for chlorothiazide; reserpine.

Summary for Generic Name: chlorothiazide; reserpine

US Patents:0
Tradenames:5
Applicants:4
NDAs:7
Drug Master File Entries: see list41
Bulk Api Vendors: see list1
Clinical Trials: see list18
Patent Applications: see list5
Drug Prices:see low prices
DailyMed Link:chlorothiazide; reserpine at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms
CHLOROTHIAZIDE AND RESERPINE
chlorothiazide; reserpine
TABLET;ORAL088365-001Dec 22, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
DIUPRES-250
chlorothiazide; reserpine
TABLET;ORAL011635-003Aug 26, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
CHLOROTHIAZIDE-RESERPINE
chlorothiazide; reserpine
TABLET;ORAL087745-001May 6, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
CHLOROTHIAZIDE AND RESERPINE
chlorothiazide; reserpine
TABLET;ORAL088557-001Dec 22, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
CHLOROTHIAZIDE-RESERPINE
chlorothiazide; reserpine
TABLET;ORAL087744-001May 6, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
CHLOROTHIAZIDE W/ RESERPINE
chlorothiazide; reserpine
TABLET;ORAL088151-001Jun 9, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Merck
DIUPRES-500
chlorothiazide; reserpine
TABLET;ORAL011635-006Aug 26, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
CHLOROTHIAZIDE W/ RESERPINE
chlorothiazide; reserpine
TABLET;ORAL084853-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
McKinsey
Cantor Fitzgerald
Healthtrust
AstraZeneca
Chinese Patent Office
Daiichi Sankyo
Fuji
Farmers Insurance
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot